| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.001 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |